|
|
|
|
|
|
by Retric
4810 days ago
|
|
|
the number of FDA-regulated investigators running trials abroad has increased by 15 percent each year, while the number of U.S.-based investigators declined 5.5 percent annually. Several forces are pushing trials elsewhere, the researchers noted: cost (a trial at a top medical center in India may cost less than one-tenth per patient what it would cost at a second-tier U.S. center); faster approval times; and less red tape. http://health.usnews.com/health-news/managing-your-healthcar... PS: Of note: In the US, sponsors may receive a 50% tax credit for certain clinical trials. http://en.wikipedia.org/wiki/Clinical_trial#Economics |
|
|